v3.25.4

LEASES	12 Months Ended
	Dec. 31, 2024
Aspire Biopharma Inc [Member]
LEASES	NOTE 5 - LEASES The company does not lease facilities under any operating lease arrangement. Intermittently the Company has rented office space on an as needed basis from a related party. Total rent expense for the months ended December 31, 2024 and 2023 was $6,500 and $0, respectively.

X

- Definition

The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 842
-SubTopic 20
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/842-20/tableOfContent

+ Details

Name:	us-gaap_LesseeOperatingLeasesTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	srt_ConsolidatedEntitiesAxis=ASBP_AspireBiopharmaIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: